<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/66802" />
  <subtitle />
  <id>http://dspace.bsuedu.ru/handle/123456789/66802</id>
  <updated>2026-10-15T01:26:16Z</updated>
  <dc:date>2026-10-15T01:26:16Z</dc:date>
  <entry>
    <title>The C3435T genetic polymorphism of the ABCB1 (MDR1) gene as a predictor of antihypertensive efficacy of losartan monotherapy in newly diagnosed arterial hypertension</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/67113" />
    <author>
      <name>Shelekhova, T. V.</name>
    </author>
    <author>
      <name>Ruta, A. V.</name>
    </author>
    <author>
      <name>Luchinina, E. V.</name>
    </author>
    <author>
      <name>Bontsevich, R. A.</name>
    </author>
    <author>
      <name>Zaitсeva, M. R.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/67113</id>
    <updated>2026-10-13T00:05:22Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: The C3435T genetic polymorphism of the ABCB1 (MDR1) gene as a predictor of antihypertensive efficacy of losartan monotherapy in newly diagnosed arterial hypertension
Authors: Shelekhova, T. V.; Ruta, A. V.; Luchinina, E. V.; Bontsevich, R. A.; Zaitсeva, M. R.
Abstract: The aim of this research is to indicate the correlation between common SNPs C3435T and C1236T of the MDR1 gene and the efficacy of 6-week losartan monotherapy course in patients with a newly diagnosed arterial hypertension (AH)</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Evaluation of pharmacological correction of hypoxic-ischemic encephalopathy sequelae using peptide erythropoietin analogs in a mouse model of mild and moderate hypoxic-ischemic encephalopathy during the late remodeling phase</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/67111" />
    <author>
      <name>Pokrovsky, V. M.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/67111</id>
    <updated>2026-10-13T00:05:14Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Evaluation of pharmacological correction of hypoxic-ischemic encephalopathy sequelae using peptide erythropoietin analogs in a mouse model of mild and moderate hypoxic-ischemic encephalopathy during the late remodeling phase
Authors: Pokrovsky, V. M.
Abstract: In this experimental study, Epobis and Ara-290 normalized mild HIE hyperlocomotion in the open field, whereas EPO mainly improved anxiety-like behavior and only Epobis increased peripheral time toward intact levels</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Correction by neuroglutam and succicard of age-associated impairments in accelerated aging in rats with diabetes</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/67110" />
    <author>
      <name>Pokhlebin, A. A.</name>
    </author>
    <author>
      <name>Bolokhov, N. S.</name>
    </author>
    <author>
      <name>Balakin, G. Yu.</name>
    </author>
    <author>
      <name>Pustynnikov, V. E.</name>
    </author>
    <author>
      <name>Vasilyeva, O. S.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/67110</id>
    <updated>2026-10-13T00:05:25Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Correction by neuroglutam and succicard of age-associated impairments in accelerated aging in rats with diabetes
Authors: Pokhlebin, A. A.; Bolokhov, N. S.; Balakin, G. Yu.; Pustynnikov, V. E.; Vasilyeva, O. S.
Abstract: The study aimed to investigate the impact of a long-term diabetic state on the development of accelerated aging and to evaluate the efficacy of therapy with metformin, neuroglutam, and succicard in correcting associated metabolic, behavioral, and molecular impairments</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Morphometric visualization, analysis, and assessment of atherosclerotic lesions in an apolipoprotein E-deficient mouse model (ApoE−/−)</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/67108" />
    <author>
      <name>Lebedev, P. R.</name>
    </author>
    <author>
      <name>Syrykh, N. V.</name>
    </author>
    <author>
      <name>Pokrovskii, M. V.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/67108</id>
    <updated>2026-10-13T00:05:24Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Morphometric visualization, analysis, and assessment of atherosclerotic lesions in an apolipoprotein E-deficient mouse model (ApoE−/−)
Authors: Lebedev, P. R.; Syrykh, N. V.; Pokrovskii, M. V.
Abstract: In this study, an original approach to morphometric visualization, analysis, and quantitative assessment of atherosclerotic lesions of the vascular wall in an apolipoprotein E-deficient mouse model (ApoE−/−) is proposed and validated for the first time</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

